Accrued Expenses |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payables and Accruals [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accrued Expenses |
Note 5 – Accrued Expenses
Accrued expenses at September 30, 2023 (unaudited) and December 31, 2022 consisted of the following:
Accrued payroll and related liabilities included approximately $7.0 million and $7.0 million, respectively, for accrued past due payroll taxes and associated penalties and interest as of September 30, 2023 and December 31, 2022, respectively.
As of December 31, 2022, the Company had Medicare cost reports settlement reserves of $2.1 million. During the nine months ended September 30, 2023, the Company reduced its reserve amount by $1.2 million due to payments (recoupments) and various final and estimated cost report settlements leaving Medicare cost report settlement reserves of $0.9 million at September 30, 2023.
|